Want to join the conversation?
David Chu of BoA asks that in terms of the macro business, how the company is describing client budgets; if any significant drops. $FDS CEO Phil Snow said that generally there has been a lot of cost pressure & the company has been continuing to execute in that environment. So as cost pressures come down on clients, it opens opportunities for $FDS.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?